Examples
of Conventional Drugs Derived from Plants
|
xvii
|
Herbs
and Herbal Materials Approved as Over-the-Counter (OTC) Drug Ingredients by
the U.S. FDA
|
xx
|
Reasons
for Nondisclosure of Complementary and Alternative (CAM) Therapy Use With a Recognized
Potential for Risk for Adverse Events
|
xxi
|
Clinical
Studies on Bilberry (Vaccinium
myrtillus L.)
|
11
|
Clinical
Studies on Black Cohosh (Actaea
racemosa L.)
|
21
|
Clinical
Studies on Cat’s Claw (Uncaria
guianensis [Aubl.] Gmel.) [NOTE: All Cat's Claw Studies are in the same table.]
|
36
|
Clinical
Studies on Cat’s Claw (Uncaria
tomentosa [Willd.] DC.)—Focusing on Preparations Standardized to Carboxy
Alkyl Esters (CAEs)
|
36
|
Clinical
Studies on Cat’s Claw (Uncaria
tomentosa [Willd.] DC.)—Focusing on Preparations Standardized to
Pentacyclic Oxindole Alkaloids (POAs) with no Tetracyclic Oxindole Alkaloids
(TOAs)
|
37
|
Clinical
Studies on Cayenne (Capsicum spp.) [NOTE: Cayenne and Capsaicin Preparations Studies are in the same table.]
|
47
|
Clinical
Studies on Capsaicin Preparations
|
48
|
Clinical
Studies on Chamomile, German (Matricaria
recutita L.)
|
59
|
Clinical
Studies on Chaste Tree (Vitex
agnus-castus L.)
|
69
|
Clinical
Studies on Cranberry (Vaccinium
macrocarpon Aiton)
|
81
|
Clinical
Studies on Echinacea (Echinacea
spp.)
|
94
|
Clinical
Studies on Eleuthero (Eleutherococcus
senticosus [Rupr. & Maxim.] Maxim.)
|
105
|
Clinical
Studies on Ephedra (Ephedra sinica
Stapf) [NOTE: Ephedra and Ephedrine Studies are in the same table.]
|
120
|
Clinical
Studies on Ephedrine
|
121
|
Clinical
Studies on Evening Primrose (Oenothera biennis
L.)
|
131
|
Clinical
Studies on Feverfew (Tanacetum
parthenium [L.] Sch. Bip.)
|
142
|
Clinical
Studies on Flax (Linum usitatissimum
L.)
|
150
|
Clinical
Studies on Garlic (Allium sativum
L.)
|
167
|
Clinical
Studies on Ginger (Zingiber officinale
Roscoe)
|
179
|
Clinical
Studies on Ginkgo (Ginkgo biloba
L.)
|
195
|
Clinical
Studies on Ginseng, American (Panax
quinquefolius L.)
|
209
|
Clinical
Studies on Ginseng, Asian (Panax
ginseng C.A. Meyer)
|
222
|
Clinical
Studies on Berberine
|
234
|
Clinical
Studies on Hawthorn (Crataegus
spp.)
|
244
|
Clinical
Studies on Horse Chestnut (Aesculus
hippocastanum L.)
|
255
|
Clinical
Studies on Kava (Piper methysticum
G. Forst.)
|
270
|
Clinical
Studies on Licorice (Glycyrrhiza
spp.)
|
282
|
Clinical
Studies on Milk Thistle (Silybum
marianum [L.] Gaertn.)
|
293
|
Clinical
Studies on Peppermint (Mentha x piperita L.)
|
305
|
Clinical
Studies on Saw Palmetto (Serenoa repens
[W. Bartram] Small)
|
317
|
Clinical
Studies on St. John’s Wort (Hypericum perforatum
L.)
|
331
|
Clinical
Studies on Tea, Black/Green (Camellia
sinensis [L.] Kuntze)
|
345
|
Clinical
Studies on Valerian (Valeriana
officinalis L.)
|
361
|
Clinical
Studies on Pycnogenol®, French Maritime Pine Bark extract (Pinus pinaster Aiton subsp atlantica)
|
372
|
Clinical
Studies on Alluna™ Sleep
|
374
|
Clinical
Studies on Esberitox®
|
375
|
Clinical
Studies on Euvegal® forte
|
376
|
Clinical
Studies on Hochu-ekki-to®
|
377
|
Clinical
Studies on Hova®
|
378
|
Clinical
Studies on Liv.52®
|
380
|
Clinical
Studies on Mastodynon®
|
381
|
Clinical
Studies on Nutrilite® Saw Palmetto with Nettle Root
|
382
|
Clinical
Studies on Padma® 28
|
384
|
Clinical
Studies on Phytodolor®
|
386
|
Clinical
Studies on Prostagutt® forte
|
387
|
Clinical
Studies on Sinupret®
|
389
|
Commercial
Products Used in Clinical Studies Listed in Single Herb Monographs
|
398
|
Commercial
Products Used in Clinical Studies Listed in Proprietary Herbal Product
Monographs
|
404
|
Top-Selling
Herbal Supplements in Food, Drug, and Mass Market Retail Outlets [NOTE: As this table is from 2003, more current market information can be found here.]
|
409
|